Dr. Resnick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
59 Alex Dr
White Plains, NY 10605Phone+1 914-262-7765
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1974 - 1977
- Weill Cornell MedicineClass of 1974
Certifications & Licensure
- NY State Medical License 1975 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Carmustine in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme Start of enrollment: 2000 Jun 01
- Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm Start of enrollment: 2000 Jun 01
Publications & Presentations
PubMed
- 270 citationsComparison of a Second-Generation Combination Chemotherapeutic Regimen (m-BACOD) with a Standard Regimen (CHOP) for Advanced Diffuse Non-Hodgkin's LymphomaLeo I. Gordon, David P. Harrington, Janet Andersen, Joseph P. Colgan, John H. Glick
The New England Journal of Medicine. 1992-11-05 - 20 citationsAdvanced diffuse non-Hodgkin's lymphoma. Analysis of prognostic factors by the international index and by lactic dehydrogenase in an intergroup studyLeo I. Gordon, Janet Andersen, Joseph Colgan, John Glick, Gene D. Resnick
Cancer. 1995-02-01 - 25 citationsReed-Sternberg cells in Hodgkin's disease contain fibronectin.Gene D. Resnick, Ralph L. Nachman
Blood. 1981-02-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: